Global Motion Sickness Treatment Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Motion Sickness Treatment Market Overview

1.1 Motion Sickness Treatment Definition

1.2 Global Motion Sickness Treatment Market Size Status and Outlook (2019-2032)

1.3 Global Motion Sickness Treatment Market Size Comparison by Region (2019-2032)

1.4 Global Motion Sickness Treatment Market Size Comparison by Type (2019-2032)

1.5 Global Motion Sickness Treatment Market Size Comparison by Application (2019-2032)

1.6 Global Motion Sickness Treatment Market Size Comparison by Sales Channel (2019-2032)

1.7 Motion Sickness Treatment Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Motion Sickness Treatment Market Snapshot

2.2 Global Motion Sickness Treatment Market Volume & Revenue (2019-2025)

2.3 Global Motion Sickness Treatment Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Motion Sickness Treatment Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Motion Sickness Treatment Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Motion Sickness Treatment Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Motion Sickness Treatment Market Segment Analysis by Player

3.1 Global Motion Sickness Treatment Sales and Market Share by Player (2023-2025)

3.2 Global Motion Sickness Treatment Revenue and Market Share by Player (2023-2025)

3.3 Global Motion Sickness Treatment Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Motion Sickness Treatment Market Segment Analysis by Type

4.1 Global Motion Sickness Treatment Market by Type

4.1.1 Anticholinergic

4.1.2 Antihistamines

4.1.3 Others

4.2 Global Motion Sickness Treatment Sales and Market Share by Type (2019-2025)

4.3 Global Motion Sickness Treatment Revenue and Market Share by Type (2019-2025)

4.4 Global Motion Sickness Treatment Average Price by Type (2019-2025)

4.5 Leading Players of Motion Sickness Treatment by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Motion Sickness Treatment Market Segment Analysis by Application

5.1 Global Motion Sickness Treatment Market by Application

5.1.1 Hospitals

5.1.2 Retail Pharmacy

5.1.3 Others

5.2 Global Motion Sickness Treatment Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Motion Sickness Treatment by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Motion Sickness Treatment Market Segment Analysis by Sales Channel

6.1 Global Motion Sickness Treatment Market by Sales Channel

6.1.1 Global Motion Sickness Treatment Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Motion Sickness Treatment Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Motion Sickness Treatment Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Motion Sickness Treatment by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Motion Sickness Treatment Market Segment Analysis by Region

7.1 Global Motion Sickness Treatment Market Size and CAGR by Region (2019-2032)

7.2 Global Motion Sickness Treatment Sales and Market Share by Region (2019-2025)

7.3 Global Motion Sickness Treatment Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Motion Sickness Treatment Market Share by Type

7.4.3 North America Motion Sickness Treatment Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Motion Sickness Treatment Market Share by Type

7.5.3 Europe Motion Sickness Treatment Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Motion Sickness Treatment Market Share by Type

7.6.3 Asia-Pacific Motion Sickness Treatment Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Motion Sickness Treatment Market Share by Type

7.7.3 South America Motion Sickness Treatment Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Motion Sickness Treatment Market Share by Type

7.8.3 Middle East & Africa Motion Sickness Treatment Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Motion Sickness Treatment Players

8.1 Dramamine

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 GlaxoSmithKline

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Mylan

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Myungmoon Pharm

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Perrigo Company

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Pfizer

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Prestige Brands

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Reliefband Technologies

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Sandoz

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Sanofi

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Tummydrops

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 WellSpring Pharmaceutical

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Yunnan Baiyao

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Sumifun Industries

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 Others

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Motion Sickness Treatment

9.1 Industrial Chain of Motion Sickness Treatment

9.2 Upstream of Motion Sickness Treatment

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Motion Sickness Treatment

9.3.1 Leading Distributors/Dealers of Motion Sickness Treatment

9.3.2 Leading Consumers of Motion Sickness Treatment

Chapter 10. Global Motion Sickness Treatment Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Motion Sickness Treatment Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Motion Sickness Treatment Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Motion Sickness Treatment (2026-2032)

11.1 Global Motion Sickness Treatment Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Motion Sickness Treatment Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Motion Sickness Treatment Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Motion Sickness Treatment Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Motion Sickness Treatment Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Motion Sickness Treatment Import-Export (2019-2025)

12.2 Europe Motion Sickness Treatment Import-Export (2019-2025)

12.3 Asia Pacific Motion Sickness Treatment Import-Export (2019-2025)

12.4 South America Motion Sickness Treatment Import-Export (2019-2025)

12.5 Middle East & Africa Motion Sickness Treatment Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Motion Sickness Treatment Demand-Supply (2019-2025)

13.2 Europe Motion Sickness Treatment Demand-Supply (2019-2025)

13.3 Asia Pacific Motion Sickness Treatment Demand-Supply (2019-2025)

13.4 South America Motion Sickness Treatment Demand-Supply (2019-2025)

13.5 Middle East & Africa Motion Sickness Treatment Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources